Home » Newsletters » BioWorld Science

BioWorld Science

March 3, 1997

View Archived Issues

Lupus gene located by international research team

Alza updates status of products under development with TDC and discloses new technologies

Aronex Pharmaceuticals reports fourth-quarter and year-end 1996 results

CollaGenex Pharmaceuticals announces fourth-quarter and full-year 1996 results

Cubist Pharmaceuticals reports 1996 results

GeneMedicine announces fourth-quarter and year-end 1996 financial results

ID Biomedical update to shareholders

ImmuLogic reports fourth-quarter and year-end 1996 financial results

Kyowa Hakko discloses DC-107 derivatives

CCK-B/gastrin antagonists described by Rotta

New MMP inhibitors from British Biotech

Fibrinogen antagonists disclosed by Terumo

Sumitomo Metal reveals hypoglycemic/hypolipidemic agents

Tokyo Tanabe claims antifungal agents

Symphar/SKB disclose compounds with Lp(a)-lowering activity

Novel antitumor agents disclosed by Yale University

Novel polyamines fromTeva

Pharmacokinetic-pharmacodynamic interactions between terazosin and finasteride

Reports of Yoshitomi/Green Cross merger confirmed

Establishment of Gensia Sicor nearing completion

Posicor recommended for approval in the U.S.

FDA advisory panel approves carvedilol

Latex diagnostic cleared for U.S. market

BioChem Pharma and Oncogene Science expand collaboration

Genzyme and Kaken to comarket Sepra line in Japan

Preliminary phase II data on Xoma's Neuprex in trauma

IGG's MMS-1 covered by patent

Phogen formed to investigate new drug delivery concept

Gliatech receives grant for histamine H3 receptor antagonists

Incyte and OncorMed to collaborate on clinical genomics

Phase II data for ISIS-2302 in Crohn's disease

Bio Fluorescent Technologies and Immune Network Research agreement

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...